According to THE SAGE GROUP, the National Bill for the Treatment of Peripheral Artery Disease (PAD) Exceeds $14 Billion
ATLANTA—-Speaking at the New Cardiovascular Horizons meeting in New Orleans, Mary L. Yost, President of THE SAGE GROUP, released results of a new analysis of the macroeconomic costs of PAD.
Read more on Business Wire via Yahoo! Finance
Popular Posts:
- I need pros and cons about Obama’s healthcare reform bill…?
- Advice on health care reform law offered at KC forums
- Health-care reform topic of employers’ seminar
- New Health Care Bill Pros and Cons
- Can you define the Health Care Reform Bill….?